Updated January 10, 2020
“DIGEST – Protest challenging the agency’s evaluation of the protester’s quotation as unacceptable is denied where the agency reasonably found, consistent with the stated evaluation criteria, that one of the protester’s proposed key personnel failed to satisfy the solicitation’s minimum requirements.”
“BACKGROUND – FDA issued the solicitation on March 26, 2018, using Federal Acquisition Regulation (FAR) subpart 8.4 procedures. Agency Report (AR), Tab 4, RFQ Instructions and Evaluation, amend. 2, at 1, 3. The RFQ was issued to vendors holding Federal Supply Schedule (FSS) contracts under General Services Administration (GSA) Information Technology Schedule 70. AR, Tab 2, GSA e-Buy RFQ Summary, at 1. The RFQ contemplated a single-award BPA with an estimated value of $112 million and a period of performance consisting of a 12-month base period and four 1-year option period…””
“As relevant to the protest, the technical approach to the CDER DME SOW subfactor required the submission of resumes for qualified key personnel, one of which was an enterprise solutions architect. AR, Tab 4, RFQ Instructions and Evaluation, amend. 2, at 10; Tab 3C, Amended RFQ CDER SOW at 17. The agency was to evaluate the relevance of each listed key person’s experience, knowledge, certification, and identified skill sets for the ability to successfully complete the activities listed in the CDER DME SOW. AR, Tab 4, RFQ Instructions and Evaluation, amend. 2, at 15. In pertinent part, the RFQ required that the proposed enterprise solutions architect satisfy the following minimum qualifications…”
“DISCUSSION – Deloitte argues that FDA’s evaluation of its proposed enterprise solutions architect was unreasonable and failed to credit the candidate with the relevant experience listed in the resume and crosswalk. Specifically, Deloitte argues that the resume explicitly stated that the proposed candidate possessed over 20 years of experience using Hyperion and Essbase, which are “core technologies of the Oracle …”
“DECISION – Deloitte Consulting, LLP, of Arlington, Virginia, protests the establishment of a blanket purchase agreement (BPA) and issuance of a task order to Guidehouse LLP, of McLean, Virginia, under request for quotations (RFQ) No. FDA-RFQ-18-119234, issued by the Department of Health and Human Services, Food and Drug Administration (FDA), for information technology services in support of the agency’s integrated budget, acquisition, and planning system. The protester contends that the agency unreasonably concluded that its quotation was unacceptable and disqualified it from the competition.
We deny the protest.”
Updated January 9, 2020
G2X TAKE: The latest protest put forth by Deloitte related to this single award BPA to provide the FDA with Integrated Budget and Acquisition Planning Systems (IBAPS) support services has now been denied.
No details are available as to the grounds for the protest, nor the reason for the decision but they will be shared here as they are made available. Details on the award made to Guidehouse are available in the thread below.
Posted October 3, 2019
G2X TAKE: Late last week, the Food and Drug Administration awarded Guidehouse a single award BPA to provide the Agency with Integrated Budget and Acquisition Planning Systems (IBAPS) support services. The BPA was competed on GSA IT-70, drawing one other bid.
A protest was subsequently filed by Deloitte with GAO. No details have been provided as to the grounds for the protest. A decision is expected by GAO no later than January 9th of 2020.
This recent action filed with GAO is the latest in a series of protests levied by Deloitte and Guidehouse over the past year, drawing out the competition for this 5-year IT Life Cycle Support Services BPA. Read More Here.
- Released on GSA IT-70 in the Spring of 2018, the focus of IBAPS II is on the continued expansion of IBAPS to 9 FDA Centers; integration with internal and external budget and finance systems to create data flow efficiencies; creation of business analytics reports to support forecasting and track variances; and configuration of the IBAPS instance at other HHS OpDivs. The initial SOW and details on incumbent PwC (now Guidehouse) are available here.
- Acquired by an affiliate of Veritas Capital on May 1, 2018, Guidehouse, the former PwC Public Sector group, rolled out their new website and brand this time last summer.
- Guidehouse was identified early this year as one of the Federal Health consulting firms creating a BUZZ.